Detection of vaccine-derived polioviruses in Mexico using environmental surveillance

Journal of Infectious Diseases

Volumn 210, Issue , 2014, Pages S315-S323

  Esteves Jaramillo, Alejandra ^a   Estivariz, Concepcin F ^b   Pearanda, Silvia ^c   Richardson, Vesta L ^a   Reyna, Jess ^a   Coronel, Diana L ^a   Carrin, Veronica ^d   Landaverde, Jose M ^d   Wassilak, Steven G F ^b   Prez Snchez, Elda E ^e   Lpez Martinez, Irma ^e   Burns, Cara C ^c   Pallansch, Mark A ^c  

^a Centro Nacional Para la Salud de la Infancia y Adolescencia   (Mexico)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^d PAN AMERICAN HEALTH ORGANIZATION   (United States)

^e Instituto de Diagnóstico y Referencia Epidemiológico   (Mexico)

Author keywords

environmental surveillance; inactivated poliovirus vaccine; polio; vaccine derived poliovirus

Indexed keywords

ACUTE FLACCID PARALYSIS; ARTICLE; ENVIRONMENTAL MONITORING; FLACCID PARALYSIS; MASS IMMUNIZATION; MEXICO; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLIOMYELITIS VIRUS; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SEWAGE; TREND STUDY; VACCINE DERIVED POLIOVIRUS TYPE 1; VIRUS DETECTION; VIRUS ISOLATION; VIRUS STRAIN; ADOLESCENT; CHILD; CLASSIFICATION; FEMALE; GENETICS; HUMAN; INFANT; ISOLATION AND PURIFICATION; MALE; NEWBORN; PRESCHOOL CHILD; TIME; VIROLOGY;

ORAL POLIOMYELITIS VACCINE; SEWAGE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; ENVIRONMENTAL MONITORING; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MEXICO; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; SEWAGE; TIME FACTORS;

EID: 84910619431     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu183     Document Type: Article

References (42)

1. Sutter RW, Kew OM, Cochi SL. Poliovirus vaccine-live. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. Philadelphia: Saunders, 2008:631-85.
2. Estívariz CF, Pallansch MA, Anand A, et al. Poliovirus vaccination options for achieving eradication and securing the endgame. Curr Opin Virol 2013; 3:309-15.
3. Alexander LN, Seward JF, Santibanez TA, et al. Vaccine policy changes and epidemiology of poliomyelitis in the United States. JAMA 2004; 292:1696-701.
4. Strebel PM, Sutter RW, Cochi SL, et al. Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-Associated disease. Clin Infect Dis 1992; 14:568-79.
5. Kew OM,Wright PF, Agol VI, et al. Circulating vaccine-derived polioviruses: current state of knowledge. Bull World Health Organ 2004; 82:16-23.
6. Minor P. Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication. Vaccine 2009; 27:2649-52.
7. Estívariz CF, Watkins MA, Handoko D, et al. A large vaccine-derived poliovirus outbreak on Madura Island-Indonesia, 2005. J Infect Dis 2008; 197:347-54.
8. Burns CC, Shaw J, Jorba J, et al. Multiple independent emergences of type 2 vaccine-derived pol ioviruses during a large outbreak in northern Nigeria. J Virol 2013; 87:4907-22.
9. The Global Polio Eradication Initiative. Data and monitoring. http://www.polioeradication.org. Accessed 7 August 2013.
10. Wassilak S, Pate MA, Wannemuehler K, et al. Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population. J Infect Dis 2011; 203:898-909.
11. Wringe A, Fine PE, Sutter RW, Kew OM. Estimating the extent of vaccine-derived poliovirus infection. PLOS ONE 2008; 3:e3433.
12. Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Ann Rev Microbiol 2005; 59:587-635.
13. Alexander JP, Ehresmann K, Seward J, et al. Transmission of imported vaccine-derived poliovirus in an undervaccinated community in Minnesota. J Infect Dis 2009; 199:391-7.
14. Global Polio Eradication Initiative. Polio Eradicat ion & Endgame Strategic Plan 2013-2018 2013. WHO/POLIO/13.02. http://www.polioeradication.org/Portals/0/Document/Resources/StrategyWork/PEESP-EN-US.pdf. Accessed 15 November 2013.
15. Thompson KM, Duintjer Te bbens RJ, Pallansch MA, et al. Development and consideration of global policies for managing the future risks of poliovirus outbreaks: insights and lessons learned through modeling. Risk Anal 2006; 26:1571-80.
16. Aylward B, Yamada T. The polio endgame. N Engl J Med 2011; 364:2273-5.
17. Schaap GJ, Bijkerk H, Coutinho RA, Kapsenberg JG, Van Wezel AL. The spread of wild poliovir us in the well-vaccinated Netherlands in connection with the 1978 epidemic. Prog Med Virol 1984; 29: 124-40.
18. Sutter RW, Patriarca PA, Brogan S, et al. Outbreak of paralytic poliomye litis in Oman: evidence for widespread transmission among fully vaccinated children. Lancet 1991; 338:715-20.
19. Hovi T, Shulman LM, van der Avoort H, Deshpande J, Roivainen M, De Gourville EM. Role of environmental poliovirus surveillance in global polio eradication and beyond. Epidemiol Infect 2012; 140:1-13.
20. World Health Organization. Global Alert and Response (GAR). Poliovirus detected from environmental samples in Israel-update 15 July 2013, 2013. http://www.who.int/csr/don/2013-07-15/en/. Acc essed 18 October 2013
21. deQuadros CA, Hersh BS, Olive JM, Andrus JK, da Silveira CM, Carrasco PA. Eradication of wild poliovirus from the Americas: acute flaccid paralysis surveillance, 1988- 1995. J Infect Dis 1997; 175 (suppl 1):S37-42.
22. National Immunization Council. Manual for Immunization 2008- 2009. Mexico City, Mexico: Secretariat of Health, 2008.
23. Mas Lago P,Gary HE Jr.,Perez LS,et al. Poliovirus detection in wastewater and stools following an immunization campaign in Havana, Cuba. Int J Epidemiol 2003 32 772-7.
24. Poyry T, Stenvik M, Hovi T. Viruse s in sewage waters during and after a poliomyelitis outbreak and subsequent nationwide oral poliovirus vaccination campaign in Finland. App Environ Microbiol 1988; 54:371-4.
25. World Health Organization. Department of Immunization, Vaccines and Biologicals. Guidelines for Environmental Surveillance of Poliovirus Circulation. WHO/V&B/03.03. Geneva, Switzerland: 2003.
26. Blomqvist S, Savolainen C, Laine P, et al. Ch aracterization of a highly evolved vaccine-derived poliovirus type 3 isolated from sewage in Estonia. J Virol 2004; 78:4876-83.
27. Shulman L, Manor Y, Sofer D, et al. Neurovirulent vaccine-derived polioviruses in sewage from highly immune populations. PLOS ONE 2006; 1:e69-69.
28. World Health Organization. Department of Immunization, Vaccines and Biologicals. Polio laboratory manual. 4th Edition. WH O/IVB/04.10.World Health Organization ed. Geneva,World Health Organization, 2004.
29. World Health Organization. Department of Immunization, Vaccines and Biologicals. Supplement 1to the WHO Polio Laboratory Manual. An alternative test algorithm for poliovirus isolation and characterization. http://www.who.int/immunization-monitoring/Supplement-polio-lab-manual.pdf. Accessed 15 November 2013.
30. Kilpatrick DR, Yang CF, Ching K, et al. Rapid group-, serotype-, and vaccine strain-specific identification of poliovirus isolates by real-time reverse transcription-PCR using degenerate primers and probes containing deoxyinosine residues. J Clin Microbiol 2009; 47:1939-41.
31. Kilpatrick DR, Ching K, Iber J, et al. Identification of vaccine-derived polioviruses using udal-stage real-time RT-PCR. J Virol Methods 2014; 197:25-8.
32. Kilpatrick DR, Iber JC, Chen Q, et al. Serotype-specific sequencing primers. J Virol Methods 2011; 174:128-130.
33. El Bassioni L, Barakat I, Nasr E, et al. Prolonged detection of indigenous wild polioviruses in sewage from communities in Egypt. Am J Epidemiol 2003; 158:807-15.
34. Jorba J, Campagnoli R, De L, Kew O. Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range. J Virol 2008; 82:4429-40.
35. Pan American Health Organization. Poliomyelitis eradication. In: Field Guide. Third Edition. Pan American Health Organization ed. Washington DC, Pan American Health Organization, 2006. http://www2.paho.org/hq/dmdocuments/2010/FieldGuide-Polio-3rdEd-e.pdf. Accessed 15 November 2013.
36. Consejo Nacional del Población. Proyecciones de la Poblacion de los Municipios de Mexico 2010-2030. http://www.conapo.gob.mx/es/CONAPO/De-los-municipios-de-Mexico-2010-2030. Accessed 30 June 2013.
37. Centers for Disease Control and Prevention. Update on vaccine-derived polioviruses. MMWR Morb Mortal Wkly Rep 2006; 55:1093-7.
38. Centers for Disease Control and Prevention. Update on Vaccine-Derived Polioviruses-Worldwide, January 2008-June 2009. MMWR Morb Mortal Wkly Rep 2009; 58:1002-6.
39. Centers for Disease Control and Prevention. Update on vaccine-derived polioviruses-worldwide, April 2011-June 2012. MMWR Morb Mortal Wkly Rep 2012; 61:741-6.
40. Conyn-van Spaendonck MA, Oostvogel PM, van Loon AM, van Wijngaarden JK, Kromhout D. Circulation of poliovirus during the poliomyelitis outbreak in The Netherlands in 1992-1993. Am J Epidemiol 1996; 143:929-35.
41. Rakoto-Andrianarivelo M, Gumede N, Jegouic S, et al. Reemergence of recombinant vaccine-derived poliovirus outbreak in Madagascar. J Infect Dis 2008; 197:1427-35.
42. World Health Organization. Summary of discussions and recommendations of the 18th Informal Consultation of the Global Polio Labora tory Network 28th-29th June 2012. http://www.polioeradication.org/Portals/0/Document/Resources/GPLN-publications/GPLN-Meeting-recommendations-2012.pdf. Accessed 15 November 2013.